INS and Hypoglycemia: However, no discernible difference was found between the MDI and continuous subcutaneous insulin infusion (CSII) group in terms of HbA1c, the proportion of hypoglycemia events, and insulin dose (7.42 ± 0.74 vs 7.49 ± 0.84%, 59.1 vs 57.1% and 0.49 ± 0.20 vs 0.44 ± 14 units/kg/day, P > 0.05).